Septrin in the treatment of dermatitis cruris pustulosa et atrophicans.
The results of treatment of 30 Nigerian patients suffering from dermatitis cruris pustulosa et atrophicans by a 7-week course of Septrin are described. Septrin was effective in twenty-three of twenty-four patients who completed the study. The best therapeutic effects were observed in the early, pustular phase of the disease.
D000293:Adolescent; D000328:Adult; D003872:Dermatitis / Q000188:drug therapy*; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use*
D004338:Drug Combinations; D014295:Trimethoprim; D013420:Sulfamethoxazole